(Q42454010)

31 October 2017

title

Impaired beta-cell compensation to dexamethasone-induced hyperglycemia in women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

31 October 2017

1 reference

1 reference

1 reference

1 reference

7

Claudio Cobelli

1 reference

31 October 2017

4

Melissa K Cavaghan

1 reference

31 October 2017

David A Ehrmann

1

1 reference

31 October 2017

Elena Breda

2

1 reference

31 October 2017

Matthew C Corcoran

3

1 reference

31 October 2017

Jacqueline Imperial

5

1 reference

31 October 2017

Gianna Toffolo

6

1 reference

31 October 2017

Kenneth S Polonsky

8

1 reference

31 October 2017

publication date

9 December 2003

1 reference

American Journal of Physiology - Endocrinology and Metabolism

31 October 2017

published in

1 reference

31 October 2017

volume

287

1 reference

31 October 2017

issue

2

1 reference

31 October 2017

page(s)

E241-6

1 reference

SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies.

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

Insulin release in impaired glucose tolerance: oral minimal model predicts normal sensitivity to glucose but defective response times

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

Interactions between insulin resistance and insulin secretion in the development of glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

Characterization of seven C-peptide antisera

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

Quantitative indexes of beta-cell function during graded up&down glucose infusion from C-peptide minimal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00475.2003

10.1152/AJPENDO.00475.2003

21 January 2018

Identifiers

DOI

1 reference

release_idjjzs54mrcgtl4yfbpmnw2gk4

31 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/idjjzs54mrcgtl4yfbpmnw2gk4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference